A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder

Manning, Victoria (Primary Chief Investigator (PCI))
Garfield, Joshua (Chief Investigator (CI))
Arunogiri, Shalini (Chief Investigator (CI))
Lubman, Dan (Chief Investigator (CI))
Gavin, Jeffery (Chief Investigator (CI))
Kotler, Eli (Chief Investigator (CI))
George, Suzanne (Chief Investigator (CI))
Okedara, Goke (Chief Investigator (CI))
Hopwood, Malcolm J. (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	24/01/20 → 31/03/22

Funding

National Centre for Clinical Research on Emerging Drugs: A$97,595.30

1 Article

Protocol for the methamphetamine approach-avoidance training (MAAT) trial, a randomised controlled trial of personalised approach bias modification for methamphetamine use disorder
Garfield, J. B. B., Piercy, H., Arunogiri, S., Lubman, D. I., Campbell, S. C., Sanfilippo, P. G., Gavin, J., Hopwood, M., Kotler, E., George, S., Okedara, G., Piccoli, L. R. & Manning, V., 6 Jan 2021, In: Trials. 22, 1, 13 p., 21.
Research output: Contribution to journal › Article › Other › peer-review

Open Access

6 Citations (Scopus)